Vaginal dinoprostone as an adjuvant to intramuscular diclofenac for pain relief during hysterosalpingography in Federal Teaching Hospital Lokoja: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202508805772909

Enrollment

112

Registered

2025-08-04

Start date

2024-12-18

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

vitamin C and 75mg of intramuscular diclofenac

vaginal dinoprostone and 75mg of intramuscular diclofenac

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women with infertility referred for hysterosalpingography that gave consent will be recruited into the study

Exclusion criteria

Exclusion criteria: History of and allergy to local radio-opaqe dye or anti-inflammatory medications History of peptic ulcer disease History of pelvis inflammatory disease History of cervical surgery Non consenting women

Design outcomes

Primary

Measure	Time frame
Patient pain score will be assess at the various stages of the procedure, 30 m6after the procedure and 24 after the procedure via phone call	—

Secondary

Measure	Time frame
who need additional analgesics, and the side effects of the study medications.;The secondary outcomes include the number of women who need additional analgesics, and the side effects of the study medications.	—

Countries

Nigeria

Contacts

Public ContactOluwole Folashade

Public servant

folashade50@gmail.com+23408130807638

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026